Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
7.31
-0.23 (-3.05%)
At close: Oct 23, 2026, 4:00 PM EDT
7.40
+0.09 (1.23%)
Pre-market: Oct 26, 2026, 7:20 AM EDT
Immatics Market Cap
Immatics has a market cap or net worth of $999.2 million as of October 23, 2026. It is the 10,070th most valuable company in the world and the 2,237th biggest in the United States. Its market cap has decreased by 18.86% in one year.
Market Cap
999.20M
Enterprise Value
566.50M
1-Year Change
-18.86%
Global Rank
Country Rank
#2,237 United States
Category
ChartMarket Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $999.20M, an increase of 479.25%. That is a compound annual growth rate of 25.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 999.20M | -29.02% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 1.10B |
| Seaport Therapeutics | 1.08B |
| Vor Biopharma | 1.08B |
| Savara | 1.08B |
| Latigo Biotherapeutics | 1.04B |
| MannKind | 1.02B |
| Janux Therapeutics | 1.02B |
| MoonLake Immunotherapeutics | 986.39M |